Glenmede Trust CO Na Takeda Pharmaceutical CO LTD Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

A detailed history of Glenmede Trust CO Na transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Glenmede Trust CO Na holds 10,192 shares of TAK stock, worth $134,228. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,192

Previous 16,499 38.23%

Holding current value

$134,228

Previous $213,000 32.39%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$13.0 - $15.08 $81,991 - $95,109	-6,307 Reduced 38.23%	10,192 $144,000
Q2 2024 Aug 14, 2024	SELL	$12.6 - $13.67 $28,098 - $30,484	-2,230 Reduced 11.91%	16,499 $213,000
Q1 2024 May 15, 2024	BUY	$13.89 - $15.04 $180 - $195	13 Added 0.07%	18,729 $260,000
Q4 2023 Feb 13, 2024	BUY	$13.36 - $15.43 $99,638 - $115,076	7,458 Added 66.25%	18,716 $267,000
Q3 2023 Nov 14, 2023	SELL	$15.03 - $16.32 $96,868 - $105,182	-6,445 Reduced 36.41%	11,258 $174,000
Q1 2023 May 15, 2023	BUY	$15.28 - $16.48 $63,794 - $68,804	4,175 Added 30.86%	17,703 $291,000
Q4 2022 Feb 14, 2023	SELL	$12.42 - $15.62 $30,130 - $37,894	-2,426 Reduced 15.21%	13,528 $211,000
Q3 2022 Nov 16, 2022	SELL	$12.8 - $28.65 $4,889 - $10,944	-382 Reduced 2.34%	15,954 $206,000
Q2 2022 Aug 15, 2022	SELL	$13.12 - $15.03 $20,716 - $23,732	-1,579 Reduced 8.81%	16,336 $228,000
Q1 2022 May 16, 2022	BUY	$13.54 - $15.35 $8,137 - $9,225	601 Added 3.47%	17,915 $255,000
Q4 2021 Feb 15, 2022	SELL	$13.17 - $16.4 $84,446 - $105,156	-6,412 Reduced 27.03%	17,314 $235,000
Q3 2021 Nov 15, 2021	BUY	$16.3 - $17.26 $16,120 - $17,070	989 Added 4.35%	23,726 $387,000
Q2 2021 Aug 16, 2021	BUY	$16.55 - $18.64 $146,037 - $164,479	8,824 Added 63.42%	22,737 $381,000
Q1 2021 May 18, 2021	BUY	$16.71 - $19.9 $232,486 - $276,868	13,913 New	13,913 $253,000
Q4 2020 Feb 16, 2021	SELL	$15.39 - $18.97 $156,500 - $192,905	-10,169 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.1 - $19.19 $27,171 - $30,492	1,589 Added 18.52%	10,169 $181,000
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $31,660 - $42,315	-2,170 Reduced 20.19%	8,580 $153,000
Q4 2019 Feb 12, 2020	BUY	$16.88 - $20.83 $8,102 - $9,998	480 Added 4.67%	10,750 $211,000
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $807 - $899	-50 Reduced 0.48%	10,270 $175,000
Q2 2019 Aug 13, 2019	SELL	$16.58 - $20.49 $3.63 Million - $4.49 Million	-219,114 Reduced 95.5%	10,320 $181,000
Q1 2019 May 14, 2019	BUY	$16.7 - $21.52 $189,528 - $244,230	11,349 Added 5.2%	229,434 $4.67 Million
Q4 2018 Feb 14, 2019	SELL	$15.64 - $21.1 $2.39 Million - $3.23 Million	-152,906 Reduced 41.22%	218,085 $3.67 Million
Q3 2018 Nov 15, 2018	BUY	$19.54 - $21.81 $39,685 - $44,296	2,031 Added 0.55%	370,991 $7.94 Million
Q2 2018 Aug 15, 2018	BUY	$18.98 - $24.95 $6.94 Million - $9.13 Million	365,884 Added 11894.8%	368,960 $7.79 Million
Q4 2017 Feb 15, 2018	BUY	$26.96 - $28.56 $24,884 - $26,360	923 Added 42.87%	3,076 $86,000
Q3 2017 Nov 14, 2017	BUY	$26.6 - $28.23 $57,269 - $60,779	2,153	2,153 $0

Others Institutions Holding TAK

# of Institutions

338

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $40.9B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Takeda Pharmaceutical CO LTD Transaction History